Heath Jason Mark Ellison

Affiliations

  • Chief Development Officer at Opiant Pharmaceuticals Inc. (OPNT), 2023-03-03
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
OPNT $20.26 610 $12,358.60 18,751 2023-01-27 Filing
OPNT $20.20 469 $9,473.80 19,361 2023-01-09 Filing
OPNT $20.20 1,806 $36,481.20 19,830 2023-01-05 Filing